THROMBOCYTHEMIA ESSENTIAL

Clinical trials for THROMBOCYTHEMIA ESSENTIAL explained in plain language.

Never miss a new study

Get alerted when new THROMBOCYTHEMIA ESSENTIAL trials appear

Sign up with your email to follow new studies for THROMBOCYTHEMIA ESSENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for essential thrombocythemia patients: experimental drug targets overactive platelet production

Disease control Ongoing

This phase 2 trial tests an experimental drug called IMG-7289 in 9 adults with essential thrombocythemia, a rare blood disorder causing too many platelets. The drug aims to lower platelet counts and ease symptoms. Participants take a daily pill, with doses adjusted individually. …

Matched conditions: THROMBOCYTHEMIA ESSENTIAL

Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control

Last updated Jun 26, 2026 15:31 UTC

THROMBOCYTHEMIA ESSENTIAL

Get alerted when new THROMBOCYTHEMIA ESSENTIAL trials appear

New hope for essential thrombocythemia patients: experimental drug targets overactive platelet production